LIVE MARKET TRACKER :   BSE SENSEX   29380.73      |    NSE NIFTY 8922.65    
GLOBAL MARKETS :  NASDAQ 4965.974   -0.28%    |    FSI London 6905.74   +0.24%    |    NIKKEI Japan 18703.6   -0.59%
  USD GBP EUR CAD AUD INR
USD - 0.6551 0.903 1.2427 1.2781 62.33
GBP 1.5266 - 1.3786 1.8971 1.9512 95.1548
EUR 1.1076 0.7256 - 1.3764 1.4156 69.0367
CAD 0.8048 0.5272 0.7267 - 1.0286 50.1618
AUD 0.7828 0.5128 0.7069 0.9727 - 48.7913
INR 0.016 0.0105 0.0145 0.0199 0.0205 -
Indian-Commodity  :  Corporate  :  Biocon enters into academic partnership with Trinity College of Dublin

Biocon enters into academic partnership with Trinity College of Dublin (27-Nov-2012)

Biocon has entered into academic partnership with Trinity College of Dublin. Indian students are to benefit from a new international scholarship fund that will support innovative genetics research taking place at Ireland's leading university, Trinity College Dublin, the University of Dublin, (www.tcd.ie).

Biocon, Asia's premier biotechnology company, has agreed to sponsor two annual scholarships to Trinity College Dublin that will give Indian students who demonstrate creativity, motivation and academic excellence the opportunity to travel to Ireland to work in top laboratories in Trinity College Dublin. The announcement was made during the largest-ever education mission to India, led by Minister for Training and Skills, Ciaran Cannon TD, organised by Enterprise Ireland.

Biocon is India's premier biotechnology company with a strategic focus on biopharmaceuticals and research services. Biocon produces anti-diabetic agents like Acarbose, Pioglitazone, Repaglinides and Rosiglitazone. In the biological segment it produces Insulin, Erythropoietin (EPO), Filgrastim (GCSF), Streptokinase and Monoclonal Antibodies.


Top News Today
RBI affirms the government's fiscal consolidation path; cut repo rate by 25bps
(04-Mar-2015)

RBI affirms the governmentIn a surprise move and prompt reaction to the Budget 2015-16, the Reserve Bank of India (RBI) has cut repo rate by 25 basis points or 0.25 percent to 7.5 percent, giving its affirmation to the fiscal consolidation......click on news to read complete article.

Suzlon, APSEZ and Ranbaxy Laboratories to see some action today
(04-Mar-2015)

Suzlon, APSEZ and Ranbaxy Laboratories to see some action todayIndian wind turbine maker Suzlon Energy expects to turn profitable in the fiscal year starting on April 1 after six years of losses, helped by a surge in demand for renewable energy and a reduction in......click on news to read complete article.

Global ratings agencies not much convinced with the Budget
(03-Mar-2015)

Global ratings agencies not much convinced with the BudgetAlthough the first full year budget of the new government has been termed pragmatic, it failed to turn heads of global ratings agencies and Standard & Poor's (S&P) ruled out a rating upgrade......click on news to read complete article.

International Stock News
US markets closed lower on weak motor sales
(04-Mar-2015)

US markets closed lower on weak motor salesThe US markets closed lower on Tuesday, retreating from all-time highs and the psychologically significant 5,000 level for the Nasdaq reached on Monday. Weaker-than-expected growth in monthly car sales......click on news to read complete article.

US markets closed higher; Nasdaq ends above 5,000
(03-Mar-2015)

US markets closed higher; Nasdaq ends above 5,000The US markets closed higher on Monday, with a rally lifting the Nasdaq Composite above 5,000 - a level not reached since 2000 for the tech-heavy index - while the S&P 500 and the Dow Jones Industrial......click on news to read complete article.

US markets closed lower on weak economic data
(28-Feb-2015)

US markets closed lower on weak economic dataThe US markets closed lower on Friday, with the main indexes finished the week roughly where they started it, but still booked hefty monthly gains. On the economy front, consumers spent a bundle in fourth......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.